InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by PIERCE GLENN, Director. Insider active across 2 companies, notably Global Blood Therapeutics, Inc.. Cumulatively, 5 reports have been logged. The latest transaction was disclosed on 13 January 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations5 total
3,600 shares
Common Stock
SEC:0000899243-22-022892:0·
026,300 shares0
Common Stock
SEC:0001104659-22-005021·
026,300 shares0
Common Stock
SEC:0001104659-22-005021:0·
3,037 shares
Common Stock
SEC:0000899243-21-024979·
3,037 shares
Common Stock
SEC:0000899243-21-024979:0·
5 of 5 declarations
About PIERCE GLENN
Glenn Pierce is a Board Member and Interim CSO at Global Blood Therapeutics, Inc. and Voyager Therapeutics, Inc. He plays a key role in the governance and strategic direction of these companies, bringing his expertise to the board. His involvement is essential for strategic decision-making.
